Rhon Daniel I, Cook Chad E, Cleland Joshua A, Snodgrass Suzanne J
Center for the Intrepid, Brooke Army Medical Center, JBSA Fort Sam Houston, 3551 Roger Brooke Drive, San Antonio, TX, 78234, USA.
School of Health Sciences, Faculty of Health and Medicine, The University of Newcastle, Newcastle, Australia.
Clin Rheumatol. 2021 Mar;40(3):1047-1054. doi: 10.1007/s10067-020-05307-w. Epub 2020 Aug 15.
INTRODUCTION/OBJECTIVES: Prior opioid use can influence outcomes for patients with musculoskeletal disorders. The purpose of this study was to compare downstream medical utilization-based outcomes (costs, visits, recurrent episodes) after an initial diagnosis of patellofemoral pain based on pre-injury utilization of opioids.
A total of 85,7880 consecutive patients were followed for a full 12 months before and 24 months after an initial diagnosis of patellofemoral pain (January 2009 to December 2013). Data were sourced from the Military Health System Data Repository, a single-payer closed government system. Opioid prescription fills were identified, and medical visits and costs were calculated for all knee-related medical care, to include recurrence rates in the 2-year surveillance period.
A relatively small number of individuals filled an opioid prescription in the year prior (n = 1746; 2.0%); however, these individuals had almost twice the mean costs of knee-related medical care ($1557 versus %802) and medical visits (8.4 versus 4.0). Patients with prior opioid use were more likely to have at least 1 recurrent episode of knee pain (relative risk 1.58, 95% CI 1.51, 1.65) with a higher mean number of episodes of knee pain (1.5 vs 1.8). The use of opioids with higher risk of misuse or dependency (Schedule II or III) resulted in greater medical costs (for any reason) and recurrent episodes of knee pain compared to the use of opioids in a lower risk category (Schedule IV).
Prior opioid utilization was associated with a greater number of recurrent episodes of knee pain and higher downstream medical costs compared with individuals without prior opioid use. For individuals with prior opioid utilization, opioids with higher risk of misuse or dependency (Schedule II or III) resulted in greater medical costs (for any reason) and recurrent episodes compared to the use of lower-risk opioids (Schedule IV). Key Points • Patients with prior opioid use had much greater knee-related medical costs compared to patients without prior opioid use. • Patients with prior opioid use were more likely to have additional episodes of knee pain in the following 2 years compared to patients without prior opioid use. • Prior opioid use has predicted higher costs and poor outcomes after surgery, but this is the first study to confirm similar findings in non-surgical patients.
引言/目的:既往使用阿片类药物会影响肌肉骨骼疾病患者的治疗结果。本研究的目的是比较髌股关节疼痛初次诊断后,基于损伤前阿片类药物使用情况的下游医疗利用相关结果(成本、就诊次数、复发情况)。
对总共857880例连续患者在髌股关节疼痛初次诊断前12个月及诊断后24个月进行随访(2009年1月至2013年12月)。数据来源于军事卫生系统数据仓库,这是一个单一支付方的封闭政府系统。确定阿片类药物处方配药情况,并计算所有与膝关节相关医疗护理的就诊次数和成本,包括2年监测期内的复发率。
相对较少的个体在之前一年开具了阿片类药物处方(n = 1746;2.0%);然而,这些个体的膝关节相关医疗护理平均成本几乎是其他人的两倍(1557美元对802美元),就诊次数也是两倍(8.4次对4.0次)。既往使用阿片类药物的患者更有可能至少有1次膝关节疼痛复发(相对风险1.58,95%置信区间1.51,1.65),膝关节疼痛发作的平均次数更高(1.5次对1.8次)。与使用低风险类阿片类药物(附表IV)相比,使用具有更高滥用或依赖风险的阿片类药物(附表II或III)导致更高的医疗成本(无论何种原因)和膝关节疼痛复发。
与未使用过阿片类药物的个体相比,既往使用阿片类药物与更多的膝关节疼痛复发次数和更高的下游医疗成本相关。对于既往使用阿片类药物的个体,与使用低风险阿片类药物(附表IV)相比,具有更高滥用或依赖风险的阿片类药物(附表II或III)导致更高的医疗成本(无论何种原因)和复发情况。要点 • 与未使用过阿片类药物的患者相比,既往使用阿片类药物的患者膝关节相关医疗成本要高得多。 • 与未使用过阿片类药物的患者相比,既往使用阿片类药物的患者在接下来2年中更有可能出现额外的膝关节疼痛发作。 • 既往使用阿片类药物已被预测术后成本更高且预后较差,但这是第一项在非手术患者中证实类似发现的研究。